APA 6th Edition

Morović-Vergles, J. (2013). A view to the RA treatment safety profile - what will the data on long-term biologics application bring. Reumatizam, 60 (2), 175-175. Retrieved from https://hrcak.srce.hr/123453

---

MLA 8th Edition

Morović-Vergles, Jadranka. "A view to the RA treatment safety profile - what will the data on long-term biologics application bring." Reumatizam, vol. 60, no. 2, 2013, pp. 175-175. https://hrcak.srce.hr/123453. Accessed 3 Jan. 2025.

---

Chicago 17th Edition

Morović-Vergles, Jadranka. "A view to the RA treatment safety profile - what will the data on long-term biologics application bring." Reumatizam 60, no. 2 (2013): 175-175. https://hrcak.srce.hr/123453

---

Harvard

Morović-Vergles, J. (2013). 'A view to the RA treatment safety profile - what will the data on long-term biologics application bring', Reumatizam, 60(2), pp. 175-175. Available at: https://hrcak.srce.hr/123453 (Accessed 03 January 2025)

---

Vancouver

Morović-Vergles J. A view to the RA treatment safety profile - what will the data on long-term biologics application bring. Reumatizam [Internet]. 2013 [cited 2025 January 03];60(2):175-175. Available from: https://hrcak.srce.hr/123453

---

IEEE

J. Morović-Vergles, "A view to the RA treatment safety profile - what will the data on long-term biologics application bring", Reumatizam, vol.60, no. 2, pp. 175-175, 2013. [Online]. Available: https://hrcak.srce.hr/123453. [Accessed: 03 January 2025]